***** *** ********* Progress Note */**/****  CC: IOP Check - Intraocular Pressure Check   IOP check to monitor glaucoma.  Using LUMIGAN OU QHS.    Re-eval intra ocular lens implants.  Left eye has been mattering, is stuck shut in AM.  AT helps.  He continues to have headaches on left side of temple.  He states his Dr *** blood work done last week.  Is recommending he see a neurologist.  He does notice colors are more vibrant with left eye.   HPI: ***** * ****** is a 81 y.o. male  IOP check to monitor glaucoma; no problems with drops.  He uses TheraTears OU prn but OS is mattering and stuck shut in AM.   He had negative TA biopsy so his PCP is referring him to a Neurologist.    Pain:   ***:  · No specialty comments on file.  Social History     Tobacco Use   Smoking Status Former Smoker   Smokeless Tobacco Current User      Past Medical History:   Diagnosis Date   • Glaucoma      FH: Family history includes Diabetes in his brother and paternal grandmother.  There is no history of Glaucoma.      Allergies   Allergen Reactions   • Pradaxa [Dabigatran Etexilate] Rash   • Xarelto [Rivaroxaban] Rash     Current Outpatient Medications (Ophthalmic Medications)   Medication Sig   • bimatoprost Instill 1 drop into both eyes once daily in the evening.     Current Outpatient Medications (Other)   Medication Sig   • ascorbic acid (vitamin C) Take by mouth.   • Ca Carb-Mag Cmb 11-D3-Zn Sulf Take by mouth.   • folic acid/multivit-min/lutein (CENTRUM SILVER ORAL) Take by mouth once daily.   • tamsulosin Take by mouth.     See Ophthalmology Module for Examination  Diagnostic Studies:  No diagnostic studies ordered this encounter.     IMPRESSION: 81 y.o. male with Ophthalmologic problems:     Glaucoma is stable on present therapy; continue present meds.  Recommend trial of Maxitrol OU QID.    PLAN:    Return in about 6 months (around */**/****) for TC.  Call for decreased vision, increased distortion, increased pain, new floaters or flashing lights.        ******* * *******, MD  ***** *** ********* ** ********  *** ******** *** #***  ********, ** *****-****  ***-***-****       